Categories: Healthcare

Digital Diabetes Management Market Growth Outlook Through 2024-2033

The digital diabetes management market size is expected to see exponential growth in the next few years. It will grow to $37.4 billion in 2028 at a compound annual growth rate (CAGR) of 23.2%. The growth in the forecast period can be attributed to continued diabetes epidemic, artificial intelligence (ai) and machine learning, data integration, remote care models. Major trends in the forecast period include continuous glucose monitoring (cgm), insulin delivery systems, mobile apps and wearables, patient engagement and education.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Segmentation & Regional Insights
The digital diabetes management market covered in this report is segmented –

1) By Product & Service: Devices, Application, Data Management Software & Platforms, Services
2) By Device Type: Handheld Devices, Wearable Devices
3) By End User: Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Other End Users

North America was the largest region in the digital diabetes management market in 2023. Western Europe was the second largest region in the digital diabetes management market report. The regions covered in the digital diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3414&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of diabetes is projected to propel the demand for digital diabetes management devices and related services, thereby increasing the demand for the market. Diabetes is a leading cause of death, with 30% of loss of life expectancy coming from the diagnosis of diabetes. In 2021, according to the International Diabetes Federation, a total of 537 million individuals (20-79 years old) worldwide had diabetes and according to projections, there will be 643 million diabetics worldwide by 2030 and 783 million by 2045.

Key Industry Players
Major companies operating in the digital diabetes management market include Bayer AG, Medtronic Plc, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd.

The digital diabetes management market report table of contents includes: